Ovid Therapeutics
Latest round
- Series B
Last raised
- Aug 2015
Total raised
- $75M
Investors
- 9
About Ovid Therapeutics
Ovid Therapeutics Inc.Ovid Therapeutics Inc. was founded in 2014 and is headquartered in New York, US. The company specializes in creating therapies for neurological diseases, specifically targeting epilepsies.00 mn.Ovid Therapeutics specializes in developing targeted small molecule therapies aimed at addressing neurological diseases, particularly epilepsies and brain conditions. The company’s core product offerings center around innovative compounds designed to reduce seizure frequency while enhancing safety and tolerability for patients. These therapies operate on unique or potentially best-in-class mechanisms of action, reflecting Ovid's commitment to pioneering effective treatments that could significantly alter disease trajectories. The end-users include children and adults affected by epilepsy and cerebral cavernous malformations, with the company actively engaging with these communities to inform its therapeutic development.Ovid Therapeutics generates revenue through direct partnerships and collaborations focused on the development and commercialization of its pharmaceutical products. The transaction structure typically involves agreements with healthcare institutions and specialty pharmacies, which facilitate the distribution of their therapies to patients and healthcare providers.Ovid Therapeutics is focused on expanding its product pipeline and developing new therapies aimed at treating neurological conditions, with prospective launches planned in the coming years. The company is looking to enter new markets within Europe and Asia by 2025.
Who invested in Ovid Therapeutics
9 investors across 1 round
See all investors in Ovid Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 11, 2015
Amount
$75M
Investors
Questions about Ovid Therapeutics
Who invested in Ovid Therapeutics?
Ovid Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ovid Therapeutics raised?
Ovid Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ovid Therapeutics last raise money?
Ovid Therapeutics's most recent round on record is a Series B, in Aug 2015.
What does Ovid Therapeutics do?
Ovid Therapeutics is a biotechnology company.
Where is Ovid Therapeutics headquartered?
Ovid Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Ovid Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ovid Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ovid Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.